A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAFV600E colorectal tumors
暂无分享，去创建一个
R. Bernards | S. Vandenberg | K. Shokat | D. Brunen | B. Hann | M. Moasser | C. Atreya | A. Prahallad | D. Wolf | Jean-Philippe Coppé | E. Fewings | Denise P. Muñoz | B. Pan | Changjun Wang | Y. Hwang | A. Ruiz-Saenz | Courtney A. Dreyer | Cynthia Cowdrey | V. Burghi | D. Spassov | Dana J. Ramms | C. Moelders | Cecilia Schwarzer | L. J. van ’t Veer | J. Gutkind | Eleanor Fewings